Defective Counterregulation and Hypoglycemia Unawareness in Diabetes. Mechanisms and Emerging Treatments.

Endocrinology and Metabolism Clinics of North America

Volumn 42, Issue 1, 2013, Pages 15-38

  Reno, Candace M ^a   Litvin, Marina ^a   Clark, Amy L ^b   Fisher, Simon J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Brain; Counterregulation; Diabetes; Glucose; Hypoglycemia; Hypoglycemia associated autonomic failure; Hypothalamus; Unawareness

Indexed keywords

CATECHOLAMINE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; NALOXONE; PHENTOLAMINE; PROPRANOLOL;

ADRENAL MEDULLA; BLOOD GLUCOSE MONITORING; BRAIN FUNCTION; CELL COMMUNICATION; CONTINUOUS INFUSION; DIABETES MELLITUS; DISEASE SEVERITY; FUNCTIONAL ANATOMY; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GLYCOGEN ANALYSIS; HORMONAL REGULATION; HUMAN; HYPOGLYCEMIA; METABOLIC REGULATION; NEUROENDOCRINE SYSTEM; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PATIENT EDUCATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SELF MONITORING; SLEEP; SYMPATHETIC TONE;

ANIMALS; AWARENESS; CENTRAL NERVOUS SYSTEM; DIABETES MELLITUS; GLUCAGON; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPOGLYCEMIA;

EID: 84873245666     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2012.11.005     Document Type: Review

References (130)

1. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360:129-139.
2. Terry T., Raravikar K., Chokrungvaranon N., et al. Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Curr Cardiol Rep 2012, 14:79-88.
3. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-996.
4. Turner R.C., Holman R.R., Stratton I.M., et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998, 352:854-865.
5. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572. The ADVANCE collaborative group.
6. Kubiak T., Hermanns N., Schreckling H.J., et al. Assessment of hypoglycaemia awareness using continuous glucose monitoring. Diabet Med 2004, 21:487-490.
7. Cryer P.E. Hypoglycemia-associated autonomic failure in diabetes. Am J Physiol Endocrinol Metab 2001, 281:E1115-E1121.
8. Heller S.R., Choudhary P., Davies C., et al. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007, 50:1140-1147.
9. Perantie D.C., Wu J., Koller J.M., et al. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 2007, 30:2331-2337.
10. Suh S.W., Hamby A.M., Swanson R.A. Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia 2007, 55:1280-1286.
11. Puente E.C., Silverstein J., Bree A.J., et al. Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia. Diabetes 2010, 59:1055-1062.
12. Northam E.A., Rankins D., Lin A., et al. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2009, 32:445-450.
13. Asvold B.O., Sand T., Hestad K., et al. Cognitive function in type 1 diabetic adults with early exposure to severe hypoglycemia: a 16-year follow-up study. Diabetes Care 2010, 33:1945-1947.
14. Tanenberg R.J., Newton C.A., Drake A.J. Confirmation of hypoglycemia in the " dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pathol 2010, 16:244-248.
15. Feltbower R.G., Bodansky H.J., Patterson C.C., et al. Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes - Results from the Yorkshire Register of Diabetes in Children and Young Adults. Diabetes Care 2008, 31:922-926.
16. Jacobson A.M., Musen G., Ryan C.M., et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007, 356:1842-1852.
17. Skrivarhaug T., Bangstad H.J., Stene L.C., et al. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006, 49:298-305.
18. Reno C.M., Daphna-Iken D., Fisher S.J. Adrenergic blockade prevents life threatening cardiac arrhythmias and sudden death due to severe hypoglycemia. Diabetes 2012, 61:A46.
19. Frier B.M., Schernthaner G., Heller S.R. Hypoglycemia and cardiovascular risks. Diabetes Care 2011, 34:S132-S137.
20. Segel S.A., Paramore D.S., Cryer P.E. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002, 51:724-733.
21. Cryer P.E. Minireview: glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology 2012, 153:1039-1048.
22. Taborsky G.J., Mundinger T.O. Minireview: the role of the autonomic nervous system in mediating the glucagon response to hypoglycemia. Endocrinology 2012, 153:1055-1062.
23. Yue J.T., Burdett E., Coy D.H., et al. Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats. Diabetes 2012, 61:197-207.
24. DeRosa M.A., Cryer P.E. Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab 2004, 287:E32-E41.
25. Zammitt N.N., Streftaris G., Gibson G.J., et al. Modeling the consistency of hypoglycemic symptoms: high variability in diabetes. Diabetes Technol Ther 2011, 13:571-578.
26. Mitrakou A., Ryan C., Veneman T., et al. Hierarchy of glycemic thresholds for counterregulatory hormone-secretion, symptoms, and cerebral-dysfunction. Am J Physiol 1991, 260:E67-E74.
27. Borg M.A., Borg W.P., Tamborlane W.V., et al. Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes 1999, 48:584-587.
28. Tong Q.C., Ye C.P., McCrimmon R.J., et al. Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab 2007, 5:383-393.
29. Page K.A., Arora J., Qiu M., et al. Small decrements in systemic glucose provoke increases in hypothalamic blood flow prior to the release of counterregulatory hormones. Diabetes 2009, 58:448-452.
30. Watts A.G., Donovan C.M. Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation. Front Neuroendocrinol 2010, 31:32-43.
31. Borg M.A., Sherwin R.S., Borg W.P., et al. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 1997, 99:361-365.
32. de Vries M.G., Lawson M.A., Beverly J.L. Hypoglycemia-induced noradrenergic activation in the VMH is a result of decreased ambient glucose. Am J Physiol Regul Integr Comp Physiol 2005, 289:R977-R981.
33. Kang L., Routh V.H., Kuzhikandathil E.V., et al. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 2004, 53:549-559.
34. Routh V.H. Glucose sensing neurons in the ventromedial hypothalamus. Sensors (Basel) 2010, 10:9002-9025.
35. Medeiros N., Dai L., Ferguson A.V. Glucose-responsive neurons in the subfornical organ of the rat-a novel site for direct CNS monitoring of circulating glucose. Neuroscience 2012, 201:157-165.
36. Dallaporta M., Himmi T., Perrin J., et al. Solitary tract nucleus sensitivity to moderate changes in glucose level. Neuroreport 1999, 10:2657-2660.
37. Shapiro R.E., Miselis R.R. The central neural connections of the area postrema of the rat. J Comp Neurol 1985, 234:344-364.
38. Paranjape S.A., Briski K.P. Recurrent insulin-induced hypoglycemia causes site-specific patterns of habituation or amplification of CNS neuronal genomic activation. Neuroscience 2005, 130:957-970.
39. Diggs-Andrews K.A., Zhang X., Song Z., et al. Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia. Diabetes 2010, 59:2271-2280.
40. Marty N., Dallaporta M., Foretz M., et al. Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors. J Clin Invest 2005, 115:3545-3553.
41. Puente E., Daphna-Iken D., Bree A.J., et al. Impaired counterregulatory response to hypoglycemia and impaired glucose tolerance in brain glucose transporter 4 (GLUT4) knockout mice. Diabetes 2009, 58(Suppl):A13. [abstract].
42. Dunn-Meynell A.A., Routh V.H., Kang L., et al. Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 2002, 51:2056-2065.
43. Levin B.E., Becker T.C., Eiki J., et al. Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia. Diabetes 2008, 57:1371-1379.
44. McCrimmon R.J., Shaw M., Fan X.N., et al. Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia. Diabetes 2008, 57:444-450.
45. Fioramonti X., Marsollier N., Song Z.T., et al. Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation. Diabetes 2010, 59:519-528.
46. + channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. Diabetes 2005, 54:3169-3174.
47. + channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 2000, 3:757-758.
48. Davis S.N., Colburn C., Dobbins R., et al. Evidence that the brain of the conscious dog is insulin-sensitive. J Clin Invest 1995, 95:593-602.
49. Beverly J.L., De Vries M.G., Bouman S.D., et al. Noradrenergic and GABAergic systems in the medial hypothalamus are activated during hypoglycemia. Am J Physiol Regul Integr Comp Physiol 2001, 280:R563-R569.
50. Barnes M.B., Lawson M.A., Beverly J.L. Rate of fall in blood glucose and recurrent hypoglycemia affect glucose dynamics and noradrenergic activation in the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol 2011, 301:R1815-R1820.
51. Szepietowska B., Zhu W.L., Chan O.W., et al. Modulation of beta-adrenergic receptors in the ventromedial hypothalamus influences counterregulatory responses to hypoglycemia. Diabetes 2011, 60:3154-3158.
52. Saberi M., Bohland M., Donovan C.M. The locus for hypoglycemic rate of fall in glycemia-the role of portal-superior mesenteric vein glucose sensing. Diabetes 2008, 57:1380-1386.
53. Cryer P.E. Elimination of hypoglycemia from the lives of people affected by diabetes. Diabetes 2011, 60:24-27.
54. Cryer P.E. Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 2002, 45:937-948.
55. Song Z.T., Routh V.H. Recurrent hypoglycemia reduces the glucose sensitivity of glucose-inhibited neurons in the ventromedial hypothalamus nucleus. Am J Physiol Regul Integr Comp Physiol 2006, 291:R1283-R1287.
56. Geddes J., Schopman J.E., Zammitt N.N., et al. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet Med 2008, 25:501-504.
57. Schopman J.E., Geddes J., Frier B.M. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabetes Res Clin Pract 2010, 87:64-68.
58. McCrimmon R.J., Sherwin R.S. Hypoglycemia in type 1 diabetes. Diabetes 2010, 59:2333-2339.
59. McCrimmon R.J., Song Z.T., Cheng H.Y., et al. Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation. J Clin Invest 2006, 116:1723-1730.
60. McGregor V.P., Banarer S., Cryer P.E. Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia. Am J Physiol Endocrinol Metab 2002, 282:E770-E777.
61. Davis S.N., Shavers C., Davis B., et al. Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. J Clin Invest 1997, 100:429-438.
62. Davis S.N., Shavers C., Costa F., et al. Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest 1996, 98:680-691.
63. Raju B., McGregor V.P., Cryer P.E. Cortisol elevations comparable to those that occur during hypoglycemia do not cause hypoglycemia-associated autonomic failure. Diabetes 2003, 52:2083-2089.
64. Goldberg P.A., Weiss R., McCrimmon R.J., et al. Antecedent hypercortisolemia is not primarily responsible for generating hypoglycemia-associated autonomic failure. Diabetes 2006, 55:1121-1126.
65. Ramanathan R., Cryer P.E. Adrenergic mediation of hypoglycemia-associated autonomic failure. Diabetes 2011, 60:602-606.
66. Caprio S., Gerety G., Tamborlane W.V., et al. Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects. Am J Physiol 1991, 260:E852-E858.
67. Vele S., Milman S., Shamoon H., et al. Opioid receptor blockade improves hypoglycemia-associated autonomic failure in type 1 diabetes mellitus. J Clin Endocrinol Metab 2011, 96:3424-3431.
68. Poplawski M.M., Mastaitis J.W., Mobbs C.V. Naloxone, but not Valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia role of metabolic reprogramming in counterregulatory failure. Diabetes 2011, 60:39-46.
69. Galassetti P., Mann S., Tate D., et al. Effects of antecedent prolonged exercise on subsequent counterregulatory responses to hypoglycemia. Am J Physiol Endocrinol Metab 2001, 280:E908-E917.
70. Milman S., Leu J., Shamoon H., et al. Magnitude of exercise-induced beta-endorphin response is associated with subsequent development of altered hypoglycemia counterregulation. J Clin Endocrinol Metab 2012, 97:623-631.
71. Ahmet A., Dagenais S., Barrowman N.J., et al. Prevalence of nocturnal hypoglycemia in pediatric type 1 diabetes: a pilot study using continuous glucose monitoring. J Pediatr 2011, 159:297-U385.
72. Wiltshire E.J., Newton K., McTavish L. Unrecognised hypoglycaemia in children and adolescents with type 1 diabetes using the continuous glucose monitoring system: prevalence and contributors. J Paediatr Child Health 2006, 42:758-763.
73. Jones T.W., Porter P., Sherwin R.S., et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998, 338:1657-1662.
74. Banarer S., Cryer P.E. Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes-reduced awakening from sleep during hypoglycemia. Diabetes 2003, 52:1195-1203.
75. Tattersall R.B., Gill G.V. Unexplained deaths of type 1 diabetic patients. Diabet Med 1991, 8:49-58.
76. Oz G., Kumar A., Rao J.P., et al. Human brain glycogen metabolism during and after hypoglycemia. Diabetes 2009, 58:1978-1985.
77. Canada S.E., Weaver S.A., Sharpe S.N., et al. Brain glycogen supercompensation in the mouse after recovery from insulin-induced hypoglycemia. J Neurosci Res 2011, 89:585-591.
78. Alquier T., Kawashima J., Tsuji Y., et al. Role of hypothalamic adenosine 5'-monophosphate activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia. Endocrinology 2007, 148:1367-1375.
79. Herzog R.I., Chan O., Yu S., et al. Effect of acute and recurrent hypoglycemia on changes in brain glycogen concentration. Endocrinology 2008, 149:1499-1504.
80. Oz G., Tesfaye N., Kumar A., et al. Brain glycogen content and metabolism in subjects with type 1 diabetes and hypoglycemia unawareness. J Cereb Blood Flow Metab 2012, 32:256-263.
81. Mastaitis J.W., Wurmbach E., Cheng H., et al. Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia. Diabetes 2005, 54:952-958.
82. Koranyi L., Bourey R.E., James D., et al. Glucose transporter gene expression in rat brain: pretranslational changes associated with chronic insulin-induced hypoglycemia, fasting, and diabetes. Mol Cell Neurosci 1991, 2:244-252.
83. Osundiji M.A., Hurst P., Moore S.P., et al. Recurrent hypoglycemia increases hypothalamic glucose phosphorylation activity in rats. Metabolism 2011, 60:550-556.
84. Jiang L.H., Herzog R.I., Mason G.F., et al. Recurrent antecedent hypoglycemia alters neuronal oxidative metabolism in vivo. Diabetes 2009, 58:1266-1274.
85. van de Ven K.C., van der Graaf M., Tack C.J., et al. Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes mellitus. Diabetes 2012, 61(8):1974-1977.
86. Cranston I., Reed L.J., Marsden P.K., et al. Changes in regional brain (18)F-fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure. Diabetes 2001, 50:2329-2336.
87. Bingham E.M., Dunn J.T., Smith D., et al. Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [C-11]-3-O-methyl-D-glucose PET study. Diabetologia 2005, 48:2080-2089.
88. Dunn J.T., Cranston I., Marsden P.K., et al. Attenuation of amygdala and frontal cortical responses to low blood glucose concentration in asymptomatic hypoglycemia in type 1 diabetes-a new player in hypoglycemia unawareness?. Diabetes 2007, 56:2766-2773.
89. Segel S.A., Fanelli C.G., Dence C.S., et al. Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. Diabetes 2001, 50:1911-1917.
90. Arbelaez A.M., Powers W.J., Videen T.O., et al. Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition-a mechanism for hypoglycemia-associated autonomic failure. Diabetes 2008, 57:470-475.
91. Herzog R.I., Jiang L., Mason G., et al. Increased brain lactate utilization following exposure to recurrent hypoglycemia. Diabetes 2009, 58:A14.
92. Mason G.F., Petersen K.F., Lebon V., et al. Increased brain monocarboxylic acid transport and utilization in type 1 diabetes. Diabetes 2006, 55:929-934.
93. Feyter H.D., Shulman G., Rothman D., et al. Increased brain uptake of lactate in type I diabetic patients with hypoglycemia unawareness. Diabetes 2012, 61:A33.
94. Oz G., Moheet A., Emir U., et al. Hypothalamic GABA drops in response to acute hypoglycemia in healthy humans. Diabetes 2012, 61:A32.
95. Chan O., Paranjape S., Czyzyk D., et al. Increased GABAergic output in the ventromedial hypothalamus contributes to impaired hypoglycemic counterregulation in diabetic rats. Diabetes 2011, 60:1582-1589.
96. Chan O., Cheng H.Y., Herzog R., et al. Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia. Diabetes 2008, 57:1363-1370.
97. Boyle P.J., Nagy R.J., O'Connor A.M., et al. Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci U S A 1994, 91:9352-9356.
98. Reno C.M., Tanoli T., Puente E.C., et al. Deaths due to severe hypoglycemia are exacerbated by diabetes and ameliorated by hypoglycemic preconditioning. Diabetes 2011, 60:A81.
99. Smith C.B., Choudhary P., Pernet A., et al. Hypoglycemia unawareness is associated with reduced adherence to therapeutic decisions in patients with type 1 diabetes evidence from a clinical audit. Diabetes Care 2009, 32:1196-1198.
100. Matyka K., Evans M., Lomas J., et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997, 20:135-141.
101. Davis S.N., Shavers C., Costa F. Gender-related differences in counterregulatory responses to antecedent hypoglycemia in normal humans. J Clin Endocrinol Metab 2000, 85:2148-2157.
102. Sandoval D.A., Ertl A.C., Richardson M.A., et al. Estrogen blunts neuroendocrine and metabolic responses to hypoglycemia. Diabetes 2003, 52:1749-1755.
103. McGill J.B., Vlajnic A., Knutsen P.G., et al. Effect of gender on outcomes in patients with T2DM treated with insulin glargine vs comparators. Diabetes 2011, 60:A602.
104. Dagogo-Jack S., Rattarasarn C., Cryer P.E. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994, 43:1426-1434.
105. Cranston I., Lomas J., Maran A., et al. Restoration of hypoglycemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994, 344:283-287.
106. Fanelli C.G., Epifano L., Rambotti A.M., et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993, 42:1683-1689.
107. Cox D.J., Gonder-Frederick L., Polonsky W., et al. Blood glucose awareness training (BGAT-2)-long-term benefits. Diabetes Care 2001, 24:637-642.
108. Cox D.J., Kovatchev B., Koev D., et al. Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Int J Behav Med 2004, 11:212-218.
109. Hopkins D., Lawrence I., Mansell P., et al. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes the U.K. DAFNE experience. Diabetes Care 2012, 35:1638-1642.
110. Samann A., Muhlhauser I., Bender R., et al. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia 2005, 48:1965-1970.
111. Heller S.R., Colagiuri S., Vaaler S., et al. Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with type 1 diabetes. Diabet Med 2004, 21:769-775.
112. Brunelle R.L., Llewelyn J., Anderson J.H., et al. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 1998, 21:1726-1731.
113. Home P.D., Fritsche A., Schinzel S., et al. Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine. Diabetes Obes Metab 2010, 12:772-779.
114. Heller S., Buse J., Fisher M., et al. Insulin degludec, an ultra-long-acting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet 2012, 379:1489-1497.
115. Cummins E., Royle P., Snaith A., et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess 2010, 14(11):iii-iiv.
116. Gimenez M., Lara M., Conget I. Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study. Diabetes Technol Ther 2010, 12:517-521.
117. Gandhi G.Y., Kovalaske M., Kudva Y., et al. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol 2011, 5:952-965.
118. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck R.W., Hirsch I.B., et al. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009, 32:1378-1383.
119. Garg S., Brazg R.L., Bailey T.S., et al. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther 2012, 14:205-209.
120. El-Khatib F.H., Russell S.J., Nathan D.M., et al. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010, 2:27ra27.
121. Paty B.W., Senior P.A., Lakey J.R.T., et al. Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects. Diabetes Technol Ther 2006, 8:165-173.
122. Leitao C.B., Tharavanij T., Cure P., et al. Restoration of hypoglycemia awareness after islet transplantation. Diabetes Care 2008, 31:2113-2115.
123. Rickels M.R. Recovery of endocrine function after islet and pancreas transplantation. Curr Diab Rep 2012, 12(5):587-596.
124. Silverstein J., Klingensmith G., Copeland K., et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005, 28:186-212.
125. Raju B., Arbelaez A.M., Breckenridge S.M., et al. Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments. J Clin Endocrinol Metab 2006, 91:2087-2092.
126. Axelsen M., Wesslau C., Lonnroth P., et al. Bedtime uncooked cornstarch supplement prevents nocturnal hypoglycaemia in intensively treated type 1 diabetes subjects. J Intern Med 1999, 245:229-236.
127. Weinzimer S.A. Closed-loop artificial pancreas: current studies and promise for the future. Curr Opin Endocrinol Diabetes Obes 2012, 19:88-92.
128. Hardin D., Hillman D., Cattet J. Hypoglycemia alert dogs-innovative assistance for people with type I diabetes. Diabetes 2012, 61:A99.
129. Watson J.M., Jenkins E.E., Hamilton P., et al. Influence of caffeine on the frequency and perception at hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care 2000, 23:455-459.
130. de Galan B.E., Tack C.J., Lenders J.W., et al. Effect of 2 weeks of theophylline on glucose counterregulation in patients with type 1 diabetes and unawareness of hypoglycemia. Clin Pharmacol Ther 2003, 74:77-84.